Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Cash back taxes can be confusing. This guide provides essential insights to help you navigate your tax responsibilities.
22,480 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
A SpaceX AI push could rewrite how we think about tech bets. If spacex just spent billion, investors should watch how...
Comcast weighs splitting NBCUniversal from its cable and broadband unit to unlock value. History shows media spinoffs...
Grail stock surged on hype around early cancer-detection tests, then faded after a mixed trial result. This article a...
NuScale Power offers a fresh path in nuclear energy with small modular reactors. This article uncovers the simple rea...
Meta is pressing ahead with a sweeping AI infrastructure plan even after laying 8,000 employees. CEO Mark Zuckerberg ...
A playful moment from pop culture can spark practical money moves for couples. This guide shows how to turn a surpris...
Two powerhouse ideas could propel your portfolio toward the next decade: a campus-wide AI infrastructure leader and a...
As AI surges, regulators move faster than hype. Markets put odds of model access curbs at about 27.5% for 2026, reviv...
As the IoT market expands, Synaptics is recalibrating its business to capture devices beyond smartphones. This deep d...
DoorDash, Figma, and eBay report after market close, sending shares higher in extended trading. This live blog tracks...
Booking Holdings beat revenue estimates for Q4 2025, yet investors dumped shares as guidance for 2026 signaled slower...